[Corrected 8/29/18, 4:41 pm. See below.] Bristol-Myers Squibb (NYSE: [[ticker:BMY]]) has promoted Christopher Boerner to chief commercial officer. Boerner, who joined the Princeton, NJ-based pharmaceutical giant in 2015, was previously head of Bristol’s U.S. commercial organization and then its head of international markets. His experience also includes positions at Seattle Genetics (NASDAQ: [[ticker:SGEN]]), Dendreon, and Genentech. Boerner succeeds Murdo Gordon, who left Bristol earlier this month to join Amgen (NASDAQ: [[ticker:AMGN]]) as executive vice president of global commercial operations. [An earlier version of this paragraph misstated Boerner’s previous Bristol role and the location of the company’s headquarters. We regret the errors.]
